Ashtma
FDA approves GlaxoSmithKline’s Trelegy for treating asthma
September 10, 2020Research and Development Ashtma, inhaler
The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
